IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.
A 2026 analyst guide to the Medicare Drug Price Negotiation list, covering all 40 selected drugs across three rounds, negotiated Maximum Fair Prices, CMS savings estimates, and pending litigation.
A 2026 analyst guide to CTMS, eTMF, and LIMS pricing comparing Veeva, Medidata, Oracle, LabWare, Thermo Fisher, and LabVantage, with cost ranges, TCO tables, and 9 named case studies.
A 2026 analyst guide to CMS Open Payments data: 2025 program year totals of $14.67 billion, top pharma and medtech payers, payment categories, state breakdowns, and 5 enforcement case studies.
A 2026 analyst guide to FAERS adverse event data covering the FDA's new AEMS platform transition, serious outcome rates, top drugs by report volume, signal detection methods, and AI pharmacovigilance case processing.
A 2026 analyst benchmark report on clinical trial site payments covering per-visit fees, 31 to 35 percent overhead rates, holdback terms, negotiation timelines, and AI payment platforms.
A data-driven 2026 survey of AI-discovered drugs in clinical trials, mapping Insilico Medicine, Recursion Pharmaceuticals, Isomorphic Labs, success rates, funding, and named case studies.
Full 2026 data report on US drug shortages: current FDA and ASHP counts, root causes, sterile injectable and chemotherapy shortages, duration trends, hospital costs, and federal policy response.
A 2026 analyst report ranking the top 25 drugmakers by R&D spending and R&D intensity, with PhRMA, Deloitte, and IQVIA benchmarks, five case studies, and AI's impact on pharma R&D.
A 2026 analyst ranking of top contract research organizations by revenue, covering IQVIA, ICON, Fortrea, Thermo Fisher's PPD, Medpace, and CRO market size, M&A, and book-to-bill trends.
Compares Bristol Myers Squibb, Eli Lilly, and Roche's 2026 AI supercomputers: disclosed GPU counts, Nvidia Vera Rubin vs Blackwell specs, capex and market data, and five named case studies from BMS, Genentech, Recursion, and Insilico Medicine.
A 2026 analyst tracker of FDA novel drug approvals, covering CDER's 29 approvals through July, expedited-pathway data, first-cycle approval rates, and 6 named case studies.
A 2026 analyst report on the cost to bring a drug to market, comparing Tufts CSDD's $2.6 billion figure, Deloitte's $2.671 billion 2025 estimate, and lower academic estimates, with phase-by-phase trial costs and 5 case studies.
A 2026 analyst guide to EDC software pricing comparing Medidata Rave, Veeva Vault EDC, Oracle Clinical One, and Castor, with per-study cost ranges, TCO tables, and 5 case studies.
A 2026 HIPAA compliance analysis of PointClickCare's AI charting tools: the platform BAA, SOC 2 and HITRUST attestations, the $65/month FHIR API, and third-party scribes like RevMaxx, Sully.ai, and Twofold.
A 2026 analyst guide comparing ChatGPT, Claude, and purpose-built AI tools for drafting insurance claim denial appeal letters, covering HIPAA compliance, pricing, denial statistics, and four real-world cases.
A 2026 analyst guide to HIPAA training requirements for medical office staff, covering AI chatbot risks, the 2025 Security Rule proposal, penalty tiers, and enforcement case studies.
A 2026 analyst guide to AI documentation for skilled nursing facilities, covering MDS/PDPM coding assistants, AI scribes, CDI tools, HIPAA compliance, and peer-reviewed evidence on accuracy and ROI.
A July 2026 comparison of Claude Science, GPT-Rosalind, and Isomorphic Labs covering pricing, access models, published benchmarks, named enterprise adoption, and which platform fits which life-sciences use case.
A 2026 analyst comparison of ChatGPT and Claude for healthcare covering HIPAA and BAA compliance, pricing tiers, MedQA and HealthBench accuracy data, and five named hospital case studies.
2026 guide to the ChatGPT Enterprise BAA: which plans qualify for HIPAA coverage, the ~$60/seat, 150-seat pricing pattern, how to request a BAA, and vendor comparisons with Microsoft, Google, and Anthropic.
A 2026 analyst guide to de-identifying clinical notes for LLM analytics: HIPAA Safe Harbor vs Expert Determination, NER tool benchmarks for Presidio, Philter, and John Snow Labs, and re-identification risk data.
A 2026 data report on data center GPU pricing: verified H100, H200, B200, and GB200 NVL72 rental and purchase costs across 20+ cloud providers, plus capex and shortage trends.
Compares HIPAA compliance and BAA availability for ChatGPT, Claude, Microsoft Copilot, and Gemini plus clinical AI scribes like Abridge and Nabla, with 2026 pricing, KLAS survey data, and OCR enforcement cases.
A 2026 analyst guide to AI for prior authorization appeals, covering letter templates, ChatGPT prompts, tool comparisons like Claimable and Counterforce Health, denial statistics, and state AI laws.
© 2026 IntuitionLabs. All rights reserved.
